Vycor Medical (VYCO) Cash from Discontinued Operations (2019 - 2026)
Vycor Medical (VYCO) reported Cash from Discontinued Operations of 1117.0 for Q1 2026, up 2179.59% year-over-year from 49.0 in Q1 2025, and up 262.66% on a QoQ basis from 308.0 in Q4 2025.
Vycor Medical (VYCO) has 8 years of Cash from Discontinued Operations data on file, last reported at 1117.0 in Q1 2026.
- Quarterly Cash from Discontinued Operations rose 2179.59% year-over-year to 1117.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1704.0 (up 764.97% YoY) and the FY2025 annual result came in at 636.0, up 154.4% from the prior year.
- Cash from Discontinued Operations climbed to 1117.0 in Q1 2026 per VYCO's latest filing, from 308.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 1117.0 in Q1 2026 and bottomed at 1116.0 in Q2 2022.
- The 5-year median for Cash from Discontinued Operations is 53.0 (2024), against an average of 65.65.
- The widest annual swing landed in 2023, when Cash from Discontinued Operations slumped 287.82%; it then surged 2179.59% in 2026.
- Tracing VYCO's Cash from Discontinued Operations over 5 years: stood at 322.0 in 2022, then surged by 55.59% to 143.0 in 2023, then soared by 137.06% to 53.0 in 2024, then jumped by 481.13% to 308.0 in 2025, then soared by 262.66% to 1117.0 in 2026.
- Per Business Quant, the three latest VYCO Cash from Discontinued Operations figures stand at 1117.0 (Q1 2026), 308.0 (Q4 2025), and 53.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vycor Medical | - | - | 375,153.00 | 1,117.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,117.00 |
| Mar 31, 2026 | 1,117.00 |
| Dec 31, 2025 | 308.00 |
| Dec 31, 2025 | 308.00 |
| Sep 30, 2025 | 53.00 |
| Sep 30, 2025 | 53.00 |
| Jun 30, 2025 | 226.00 |
| Jun 30, 2025 | 226.00 |
| Mar 31, 2025 | 49.00 |
| Mar 31, 2025 | 49.00 |
| Dec 31, 2024 | 53.00 |
| Dec 31, 2024 | 53.00 |
| Sep 30, 2024 | 47.00 |
| Sep 30, 2024 | 47.00 |
| Jun 30, 2024 | 48.00 |
| Jun 30, 2024 | 48.00 |
| Mar 31, 2024 | 102.00 |
| Mar 31, 2024 | 102.00 |
| Dec 31, 2023 | -143.00 |
| Dec 31, 2023 | -143.00 |
| Sep 30, 2023 | 423.00 |
| Sep 30, 2023 | 423.00 |
| Jun 30, 2023 | 785.00 |
| Jun 30, 2023 | 785.00 |
| Mar 31, 2023 | -293.00 |
| Mar 31, 2023 | -293.00 |
| Dec 31, 2022 | -322.00 |
| Dec 31, 2022 | -322.00 |
| Sep 30, 2022 | -377.00 |
| Sep 30, 2022 | -377.00 |
| Jun 30, 2022 | -1,116.00 |
| Jun 30, 2022 | -1,116.00 |
| Mar 31, 2022 | 156.00 |
| Mar 31, 2022 | 156.00 |
| Dec 31, 2021 | -189.00 |
| Dec 31, 2021 | -189.00 |
| Sep 30, 2021 | -181.00 |
| Sep 30, 2021 | -181.00 |
| Jun 30, 2021 | 1,873.00 |
| Jun 30, 2021 | 1,873.00 |
| Mar 31, 2021 | -5,483.00 |
| Mar 31, 2021 | -5,483.00 |
| Dec 31, 2020 | -4,853.00 |
| Dec 31, 2020 | -4,853.00 |
| Sep 30, 2020 | -54,691.00 |
| Sep 30, 2020 | -54,691.00 |
| Jun 30, 2020 | 43,636.00 |
| Jun 30, 2020 | 43,636.00 |
| Mar 31, 2020 | -43,163.00 |
| Mar 31, 2020 | -43,163.00 |
| Dec 31, 2019 | 5,887.00 |
| Dec 31, 2019 | 5,887.00 |
| Sep 30, 2019 | -5,249.00 |
| Sep 30, 2019 | -5,249.00 |